GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Veritas In Silico Inc (TSE:130A) » Definitions » ROA %

Veritas In Silico (TSE:130A) ROA % : -0.39% (As of Jun. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Veritas In Silico ROA %?

ROA % is calculated as Net Income divided by its average Total Assets over a certain period of time. Veritas In Silico's annualized Net Income for the quarter that ended in Jun. 2024 was 円-9.4 Mil. Veritas In Silico's average Total Assets over the quarter that ended in Jun. 2024 was 円2,404.7 Mil. Therefore, Veritas In Silico's annualized ROA % for the quarter that ended in Jun. 2024 was -0.39%.

The historical rank and industry rank for Veritas In Silico's ROA % or its related term are showing as below:

TSE:130A' s ROA % Range Over the Past 10 Years
Min: -13.24   Med: -8.43   Max: 2.03
Current: -4.56

During the past 3 years, Veritas In Silico's highest ROA % was 2.03%. The lowest was -13.24%. And the median was -8.43%.

TSE:130A's ROA % is ranked better than
77.53% of 1500 companies
in the Biotechnology industry
Industry Median: -34.715 vs TSE:130A: -4.56

Veritas In Silico ROA % Historical Data

The historical data trend for Veritas In Silico's ROA % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Veritas In Silico ROA % Chart

Veritas In Silico Annual Data
Trend Dec21 Dec22 Dec23
ROA %
-13.24 -8.43 2.03

Veritas In Silico Quarterly Data
Dec21 Dec22 Sep23 Dec23 Mar24 Jun24
ROA % Get a 7-Day Free Trial - - -0.65 -17.25 -0.39

Competitive Comparison of Veritas In Silico's ROA %

For the Biotechnology subindustry, Veritas In Silico's ROA %, along with its competitors' market caps and ROA % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Veritas In Silico's ROA % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Veritas In Silico's ROA % distribution charts can be found below:

* The bar in red indicates where Veritas In Silico's ROA % falls into.



Veritas In Silico ROA % Calculation

Veritas In Silico's annualized ROA % for the fiscal year that ended in Dec. 2023 is calculated as:

ROA %=Net Income (A: Dec. 2023 )/( (Total Assets (A: Dec. 2022 )+Total Assets (A: Dec. 2023 ))/ count )
=33.048/( (1598.576+1655.531)/ 2 )
=33.048/1627.0535
=2.03 %

Veritas In Silico's annualized ROA % for the quarter that ended in Jun. 2024 is calculated as:

ROA %=Net Income (Q: Jun. 2024 )/( (Total Assets (Q: Mar. 2024 )+Total Assets (Q: Jun. 2024 ))/ count )
=-9.416/( (2416.24+2393.107)/ 2 )
=-9.416/2404.6735
=-0.39 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual ROA %, the net income of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Net Income data used here is four times the quarterly (Jun. 2024) net income data. ROA % is displayed in the 30-year financial page.


Veritas In Silico  (TSE:130A) ROA % Explanation

ROA % measures the rate of return on the total assets (shareholder equity plus liabilities). It measures a firm's efficiency at generating profits from shareholders' equity plus its liabilities. ROA % shows how well a company uses what it has to generate earnings. ROA %s can vary drastically across industries. Therefore, ROA % should not be used to compare companies in different industries. For retailers, a ROA % of higher than 5% is expected. For example, Wal-Mart (WMT) has a ROA % of about 8% as of 2012. For banks, ROA % is close to their interest spread. A bank’s ROA % is typically well under 2%.

Similar to ROE, ROA % is affected by profit margins and asset turnover. This can be seen from the Du Pont Formula:

ROA %(Q: Jun. 2024 )
=Net Income/Total Assets
=-9.416/2404.6735
=(Net Income / Revenue)*(Revenue / Total Assets)
=(-9.416 / 335.328)*(335.328 / 2404.6735)
=Net Margin %*Asset Turnover
=-2.81 %*0.1394
=-0.39 %

Note: The Net Income data used here is four times the quarterly (Jun. 2024) net income data. The Revenue data used here is four times the quarterly (Jun. 2024) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Like ROE, ROA % is calculated with only 12 months data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. ROA % can be affected by events such as stock buyback or issuance, and by goodwill, a company's tax rate and its interest payment. ROA % may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).

Many analysts argue the higher return the better. Buffett states that really high ROA % may indicate vulnerability in the durability of the competitive advantage.

E.g. Raising $43b to take on KO is impossible, but $1.7b to take on Moody's is. Although Moody's ROA % and underlying economics is far superior to Coca Cola, the durability is far weaker because of lower entry cost.


Veritas In Silico ROA % Related Terms

Thank you for viewing the detailed overview of Veritas In Silico's ROA % provided by GuruFocus.com. Please click on the following links to see related term pages.


Veritas In Silico Business Description

Traded in Other Exchanges
N/A
Address
1-11-1, Nishigotanda, Shinagawa-ku, Tokyo, JPN, 141-0031
Veritas In Silico Inc is engaged in discovery of mRNA-targeted small molecule and antisense oligonucleotide drugs. It has ibVIS platform that combines informatics (i) and experimental biology at Veritas In Silico (VIS) that will bring to fruition mRNA-targeted drugs.

Veritas In Silico Headlines

No Headlines